Dong Suk Yoon

5PUBLICATIONS
9CO-AUTHORS
Clinical pharmacology and therapeuticsProsthetics and orthoticsMedical infection agents (incl. prions)Molecular targetsLife histories
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 16, 2022
Drug repositioning of polaprezinc for bone fracture healing.

Eun Ae Ko, Yoo Jung Park, Dong Suk Yoon

|Feb 22, 2022
Correction: TLR4 downregulation by the RNA-binding protein PUM1 alleviates cellular aging and osteoarthritis.

Dong Suk Yoon, Kyoung-Mi Lee, Yoorim Choi

|Jan 16, 2022
TLR4 downregulation by the RNA-binding protein PUM1 alleviates cellular aging and osteoarthritis.

Dong Suk Yoon, Kyoung-Mi Lee, Yoorim Choi

|Jun 24, 2021
Downregulation of MicroRNA-495 Alleviates IL-1β Responses among Chondrocytes by Preventing SOX9 Reduction.

Soyeong Joung, Dong Suk Yoon, Sehee Cho

|Dec 22, 2018
MPK-1/ERK is required for the full activity of resveratrol in extended lifespan and reproduction.

Dong Suk Yoon, Dong Seok Cha, Yoorim Choi

Pageof 1